Strategic market access solutions that are evidence led and commercially focused

WRIGHT Pharma Partnering Ltd delivers a complete solution across the creation and launch phases of market access pharmaceutical strategy

HOW WE HELP

We help teams gain clarity, alignment and confidence across access, pricing and HTA evidence planning

✓ Two decades of industry experience

✓ Three years of client-focused delivery

✓ Provide structured thinking and senior insight that translates into action

✓ Delivering a suite of solutions through preferred partnership models

  • “Thank you so much Elaine for giving this guest lecture. You explained really well the importance and the intricacies of Market Access. It was of huge benefit to the students to learn from your rich experience.”

    Ronan Mahon
    National University of Ireland, Galway. Lecturer in Health Economics

  • ““Elaine Wright is one of the strongest market access experts in our business. In the nearly 10 years I have worked with Elaine she has constantly provided strong technical expertise, clear, coherent strategy, and flawless execution in support of our oncology portfolio. Her tremendous skills resulted in her being a much sought expert beyond market access, HEOR and pricing, and as a result assumed roles of increasing accountability in our global commercial business and country specific strategic leadership.””

    Brian O'Shea
    Grentech

  • “Elaine has extensive expertise in Access and Value demonstration, which is consistently shown in the high quality of her work. She is detail-focused, while maintaining a strong strategic perspective. Elaine is not only reliable but also a pleasure to collaborate with. Elaine has led several projects with us, consistently demonstrating exceptional project management skills that guarantee high-quality deliverables on time. She has deep knowledge and expertise on access, value demonstration and evidence generation topics. She quickly understands your needs and is able to transform ideas into actionable, tangible outcomes. Elaine offers invaluable insights and guidance throughout the process. In summary, working with Elaine is synonymous with success and a hallmark of quality.”

    Natalia Arrabal,
    Italiapharmaco

  • “Elaine brought  out-of-the-box innovative solutions and an energy to the team. A forward momentum and focus towards our common goal. Her pro-active problem-solving and collaborative approach made her a highly valuable team member. I would highly recommend Elaine as a peer resource, and I hope to work with her again in the future.”

    Maiko Liebermann,  F. Hoffmann-La Roche

  • Market Access Strategy Creation

    Global Market Access Strategy That’s Integrated

    We support Market Access leaders in designing cohesive, forward-looking strategy across evidence, pricing and communication. Whether you’re developing a launch plan, testing strategic scenarios or aligning cross-functional teams, we bring clarity and structure to complex environments.

    What we offer

    ✓ Market Access Strategy Development
    ✓ Scenario Planning and Design Thinking Workshops

    ✓ Global Value Dossier and Value Proposition Development

    ✓ Pricing and Access Narrative Development

  • Evidence By Design

    HTA Evidence Planning and Access and Pricing Narrative Development

    We help you build a value story that is grounded in evidence, credible across stakeholders and adaptable to country needs. From early evidence gap analysis to pricing narrative creation, we ensure your messages hold up to scrutiny and your teams are aligned on what matters.

    What we offer

    ✓ HTA and Real World Evidence Generation; Planning and Delivery

  • Implementation of Strategy

    Global Coordination for Local Reimbursement and Capability Building

    We work with global teams to support affiliates with consistent tools, messages and training. Whether preparing a submission, launching a narrative or building internal capability, we act as your team member to ensure local teams are ready, and confident.

    What we offer

    ✓ HTA and HEOR Training and Capability Building

    ✓ Coordinated Global to Local Reimbursement Submission

    ✓ Conducting Local Reimbursement Submissions in the UK and Ireland

    ✓ Global to Local Message Matrix and Q&A Resource Creation, Dissemination and Training

    ✓ Pricing Risk Scanning and Sentiment Monitoring and

    ✓ Framing the Societal Impact and Publications

    ✓ Excellence in Execution: AI Market Access and HTA Readiness and Training.

  • Designed a multi-scenario playbook for a rare disease product, addressing pricing, trial outcomes and regulatory variations. Enabled earlier alignment and readiness across cross-functional teams, helping the client prepare for potential JCA and HTA outcomes with confidence and speed.

  • Supported a mid-size biopharma with a sensitive EU launch by developing a unified pricing and access narrative. Through structured interviews and workshops, we translated complex data into clear messaging, ensuring consistency across the organisation and strengthening internal communication.

  • Created accessible, visual training modules to improve understanding of network meta-analysis among medical and commercial teams. Helped the client build internal capability to confidently communicate HTA-published evidence and engage more effectively with payers.

  • Created accessible, visual training modules to improve understanding of network meta-analysis among medical and commercial teams. Helped the client build internal capability to confidently communicate HTA-published evidence and engage more effectively with payers.

  • Developed a real-time sentiment monitoring dashboard for a rare disease launch. Anticipated pricing-related reputational risks and informed senior management with actionable insights, ensuring consistent messaging and proactive risk mitigation across European markets.

CASE STUDIES

ABOUT

A smiling young woman with shoulder-length brown hair, earrings, a white top, and a gold pendant necklace, sitting indoors with a colorful floral painting and green wall in the background.

Elaine Wright is the founder and principal consultant of WRIGHT Pharma Partnering Ltd. Elaine’s approach is structured, collaborative and outcomes-driven.

She works directly with clients to co-create strategy, align teams and guide execution across complex access challenges. Her experience spans global market access leadership roles and hands-on consulting delivery across a range of therapeutic areas including Oncology and Rare Diseases.

CONTACT

Brian O'Shea, Genentech

“Elaine Wright is one of the strongest market access experts in our business…”

Natalia Arrabal, Italfarmaco 

​“…working with Elaine is synonymous with success and a hallmark of quality.”